טוען...
Moving forward with new data and approaches: a fresh look at anthracyclines in non-Hodgkin's lymphoma
Anthracyclines have a central role in the management of non-Hodgkin's lymphoma (NHL). The cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) treatment regimen has been the standard of care for more than 20 years. Further improvements have been made to the efficacy of this chemoth...
שמור ב:
מחבר ראשי: | |
---|---|
פורמט: | Artigo |
שפה: | Inglês |
יצא לאור: |
PAGEPress Publications
2011
|
נושאים: | |
גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3269216/ https://ncbi.nlm.nih.gov/pubmed/22586509 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4081/hr.2011.s3.e1 |
תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|